Oncology Management Strategies: Best Practices for Manufacturer Success

Oncology-wpaper-heroimage-web2

Oncology management is undergoing a major shift as costs climb, competition intensifies, and treatment pathways grow more complex. In this white paper, our oncology access experts reveal how payers and providers are reshaping utilization management and why these changes are redefining what it takes to secure and maintain access.

Instead of relying on old playbooks, manufacturers now need smarter strategies that respond to the realities of a fast‑moving, data‑powered market. Our team outlines the emerging trends, the pressures shaping decision‑making, and the actions that position brands to succeed.

Oncology-wpaper-learnsection-web

What you'll learn:

  • Key forces driving the rise in oncology spending and the shift toward more assertive utilization management
  • How payers use tools such as formulary exclusions, step therapy, and new‑to‑market blocks to guide access
  • How providers rely on EHR treatment plans, internal pathways, and pharmacy‑led oversight to balance cost and clinical quality
  • How payer and provider strategies are beginning to align and where new collaborative models are emerging
  • The essential elements manufacturers need to strengthen market access planning, including scientific platforms, HEOR, pricing, and distribution

Fill out the form to access the white paper